Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

58364 1487845784HCLSReviewSingaporeFeb2017.pdf
Energy Boardroom

Pearson, Ackman appeal to shareholders after Allergan rejects Valeant's $47B offer

14.05.2014 / Fierce Pharma

Valeant CEO J. Michael Pearson, a serial acquirer, knows how to play the M&A game. After Allergan earlier this week officially spurned his company's $47 billion offer, he and partner Bill Ackman were ready with their next moves.

Cover_HCLS_Singapore LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: